Martin H. Fenner
0000-0003-1419-2405
Also known as:
M Fenner
Martin Fenner
Martin Hellmut Fenner
MH Fenner
Country: DE
Websites:
Blog
ScienceCard
Twitter
Other IDs:
Scopus Author ID: 7006600825
Personal Information
Biography
Software for Scientists.
Publications
-
Public
Blogs, Wikis und Podcasts im Unterricht Oct-2008
DOI: 10.1002/biuz.200890080Fenner, M, 2008, 'Blogs, Wikis und Podcasts im Unterricht', Biologie in unserer Zeit, vol. 38, no. 5, pp. 284-286. -
Public
Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer: World Journal of Urology 2010
DOI: 10.1007/s00345-010-0527-5www.scopus.com/inward/record.url?eid=2-s2.0-77952881651&partnerID=MN8TOARSReuter, C.W.M. and Morgan, M.A. and Ivanyi, P. and Fenner, M. and Ganser, A. and Grünwald, V., (2010). "Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer", World Journal of Urology, vol. 28, no. 3, pp. 391-398 -
Public
Chemotherapy for breast cancer brain metastases: Onkologie 2002
DOI: 10.1159/000067443www.scopus.com/inward/record.url?eid=2-s2.0-0036976431&partnerID=MN8TOARSFenner, M.H. and Possinger, K., (2002). "Chemotherapy for breast cancer brain metastases", Onkologie, vol. 25, no. 5, pp. 474-479 -
Public
Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15INK4b gene methylation and high global DNA methylation: Annals of Hematology 2009
DOI: 10.1007/s00277-008-0584-7www.scopus.com/inward/record.url?eid=2-s2.0-59049084867&partnerID=MN8TOARSLehmann, U. and Dobbelstein, C. and Fenner, M. and Römermann, D. and Hasemeier, B. and Metzig, K. and Steinemann, D. and Büsche, G. and Krauter, J. and Ganser, A. and Kreipe, H., (2009). "Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15INK4b gene methylation and high global DNA methylation", Annals of Hematology, vol. 88, no. 3, pp. 275-277 -
Public
Duplication: stop favouring applicant with longest list Mar-2008
DOI: 10.1038/452029aFenner, M, 2008, 'Duplication: stop favouring applicant with longest list', Nature, vol. 451, no. 7183, pp. 397-29. -
Public
Early events of metastasis in the microcirculation involve changes in gene expression of cancer cells: Tracking mRNA levels of metastasizing cancer cells in the chick embryo chorioallantoic membrane: American Journal of Pathology 1997
www.scopus.com/inward/record.url?eid=2-s2.0-0030984920&partnerID=MN8TOARSShioda, T. and Munn, L.L. and Fenner, M.H. and Jain, R.K. and Isselbacher, K.J., (1997). "Early events of metastasis in the microcirculation involve changes in gene expression of cancer cells: Tracking mRNA levels of metastasizing cancer cells in the chick embryo chorioallantoic membrane", American Journal of Pathology, vol. 150, no. 6, pp. 2099-2112 -
Public
Efficacy of sunitinib re-exposure after failure of an mTOR inhibitor in patients with metastatic RCC: Onkologie 2011
DOI: 10.1159/000328575www.scopus.com/inward/record.url?eid=2-s2.0-79958006072&partnerID=MN8TOARSGrünwald, V. and Weikert, S. and Seidel, C. and Busch, J. and Johannsen, A. and Fenner, M. and Reuter, C. and Ganser, A. and Johannsen, M., (2011). "Efficacy of sunitinib re-exposure after failure of an mTOR inhibitor in patients with metastatic RCC", Onkologie, vol. 34, no. 6, pp. 310-314 -
Public
Erythropoietin in cancer-related anemia Nov-2008
DOI: 10.1097/CCO.0b013e3283136971Fenner, M & Ganser, A, 2008, 'Erythropoietin in cancer-related anemia', Current Opinion in Oncology, vol. 336, no. 6, pp. 632-689. -
Public
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II: European Urology 2008
DOI: 10.1016/j.eururo.2007.12.025www.scopus.com/inward/record.url?eid=2-s2.0-38949176745&partnerID=MN8TOARSKrege, S. and Beyer, J. and Souchon, R. and Albers, P. and Albrecht, W. and Algaba, F. and Bamberg, M. and Bodrogi, I. and Bokemeyer, C. and Cavallin-Ståhl, E. and Classen, J. and Clemm, C. and Cohn-Cedermark, G. and Culine, S. and Daugaard, G. and De Mulder, P.H.M. and De Santis, M. and de Wit, M. and de Wit, R. and Derigs, H.G. and Dieckmann, K.-P. and Dieing, A. and Droz, J.-P. and Fenner, M. and Fizazi, K. and Flechon, A. and Fosså, S.D. and Garcia del Muro, X. and Gauler, T. and Geczi, L. and Gerl, A. and Germa-Lluch, J.R. and Gillessen, S. and Hartmann, J.T. and Hartmann, M. and Heidenreich, A. and Hoeltl, W. and Horwich, A. and Huddart, R. and Jewett, M. and Joffe, J. and Jones, W.G. and Kisbenedek, L. and Klepp, O. and Kliesch, S. and Koehrmann, K.U. and Kollmannsberger, C. and Kuczyk, M. and Laguna, P. and Leiva Galvis, O. and Loy, V. and Mason, M.D. and Mead, G.M. and Mueller, R. and Nichols, C. and Nicolai, N. and Oliver, T. and Ondrus, D. and Oosterhof, G.O.N. and Paz-Ares, L. and Pizzocaro, G. and Pont, J. and Pottek, T. and Powles, T. and Rick, O. and Rosti, G. and Salvioni, R. and Scheiderbauer, J. and Schmelz, H.-U. and Schmidberger, H. and Schmoll, H.-J. and Schrader, M. and Sedlmayer, F. and Skakkebaek, N.E. and Sohaib, A. and Tjulandin, S. and Warde, P. and Weinknecht, S. and Weissbach, L. and Wittekind, C. and Winter, E. and Wood, L. and von der Maase, H., (2008). "European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II", European Urology, vol. 53, no. 3, pp. 497-513 -
Public
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I: European Urology 2008
DOI: 10.1016/j.eururo.2007.12.024www.scopus.com/inward/record.url?eid=2-s2.0-38949169584&partnerID=MN8TOARSKrege, S. and Beyer, J. and Souchon, R. and Albers, P. and Albrecht, W. and Algaba, F. and Bamberg, M. and Bodrogi, I. and Bokemeyer, C. and Cavallin-Ståhl, E. and Classen, J. and Clemm, C. and Cohn-Cedermark, G. and Culine, S. and Daugaard, G. and De Mulder, P.H.M. and De Santis, M. and de Wit, M. and de Wit, R. and Derigs, H.G. and Dieckmann, K.-P. and Dieing, A. and Droz, J.-P. and Fenner, M. and Fizazi, K. and Flechon, A. and Fosså, S.D. and Garcia del Muro, X. and Gauler, T. and Geczi, L. and Gerl, A. and Germa-Lluch, J.R. and Gillessen, S. and Hartmann, J.T. and Hartmann, M. and Heidenreich, A. and Hoeltl, W. and Horwich, A. and Huddart, R. and Jewett, M. and Joffe, J. and Jones, W.G. and Kisbenedek, L. and Klepp, O. and Kliesch, S. and Koehrmann, K.U. and Kollmannsberger, C. and Kuczyk, M. and Laguna, P. and Leiva Galvis, O. and Loy, V. and Mason, M.D. and Mead, G.M. and Mueller, R. and Nichols, C. and Nicolai, N. and Oliver, T. and Ondrus, D. and Oosterhof, G.O.N. and Paz Ares, L. and Pizzocaro, G. and Pont, J. and Pottek, T. and Powles, T. and Rick, O. and Rosti, G. and Salvioni, R. and Scheiderbauer, J. and Schmelz, H.-U. and Schmidberger, H. and Schmoll, H.-J. and Schrader, M. and Sedlmayer, F. and Skakkebaek, N.E. and Sohaib, A. and Tjulandin, S. and Warde, P. and Weinknecht, S. and Weissbach, L. and Wittekind, C. and Winter, E. and Wood, L. and von der Maase, H., (2008). "European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I", European Urology, vol. 53, no. 3, pp. 478-496 -
Public
European studies of interleukin-2 in metastatic renal cell carcinoma: Seminars in Oncology 1993
www.scopus.com/inward/record.url?eid=2-s2.0-0027742554&partnerID=MN8TOARSAtzpodien, J. and Kirchner, H. and Hanninen, E.L. and Korfer, A. and Fenner, M. and Menzel, T. and Deckert, M. and Franzke, A. and Jonas, U. and Poliwoda, H., (1993). "European studies of interleukin-2 in metastatic renal cell carcinoma", Seminars in Oncology, vol. 20, no. SUPPL. 9, pp. 22-26 -
Public
Experimental animal model of hematogenous cardiac metastasis and neoplastic cardiac tamponade: Journal of Surgical Oncology 1997
DOI: 3.0.CO;2-D">10.1002/(SICI)1096-9098(199702)64:2<122::AID-JSO6>3.0.CO;2-D 3.0.CO;2-D")" style="cursor:pointer;" src="/img/spacer.gif">www.scopus.com/inward/record.url?eid=2-s2.0-0031017449&partnerID=MN8TOARSShioda, T. and Fenner, M.H. and Isselbacher, K.J., (1997). "Experimental animal model of hematogenous cardiac metastasis and neoplastic cardiac tamponade", Journal of Surgical Oncology, vol. 64, no. 2, pp. 122-126 -
Public
Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD18: Blood 2006
DOI: 10.1182/blood-2005-05-2103www.scopus.com/inward/record.url?eid=2-s2.0-33646430295&partnerID=MN8TOARSLiu, H. and Zang, C. and Fenner, M.H. and Liu, D. and Possinger, K. and Koeffler, H.P. and Elstner, E., (2006). "Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD18", Blood, vol. 107, no. 9, pp. 3683-3692 -
Public
Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-α: Evidence of a risk-benefit advantage of subcutaneous therapy: American Journal of Clinical Oncology: Cancer Clinical Trials 1994
www.scopus.com/inward/record.url?eid=2-s2.0-0028336681&partnerID=MN8TOARSSchomburg, A. and Kirchner, H. and Lopez-Hanninen, E. and Menzel, T. and Rudolph, P. and Korfer, A. and Fenner, M. and Poliwoda, H. and Atzpodien, J., (1994). "Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-α: Evidence of a risk-benefit advantage of subcutaneous therapy", American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 17, no. 3, pp. 199-209 -
Public
Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST): BMC Cancer 2012
DOI: 10.1186/1471-2407-12-186www.scopus.com/inward/record.url?eid=2-s2.0-84861217479&partnerID=MN8TOARSSeidel, C. and Fenner, M. and Länger, F. and Bantel, H. and Ganser, A. and Grünwald, V., (2012). "Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)", BMC Cancer, vol. 12 -
Public
Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer: European Journal of Cancer Part A: General Topics 1993
www.scopus.com/inward/record.url?eid=2-s2.0-0027488554&partnerID=MN8TOARSAtzpodien, J. and Kirchner, H. and Lopez Hanninen, E. and Deckert, M. and Fenner, M. and Poliwoda, H., (1993). "Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer", European Journal of Cancer Part A: General Topics, vol. 29, no. SUPPL. 5 -
Public
Key issue
DOI: 10.1629/24277
Collective action for the open researcher & contributor ID (ORCID): Serials 2011www.scopus.com/inward/record.url?eid=2-s2.0-80955157914&partnerID=MN8TOARSFenner, M. and Gómez, C.G. and Thorisson, G.A., (2011). "Key issue
Collective action for the open researcher \& contributor ID (ORCID)", Serials, vol. 24, no. 3, pp. 277-279 -
Public
Lack of therapeutic efficacy of tamoxifen in advanced renal cell carcinoma: European Journal of Cancer Part A: General Topics 1993
www.scopus.com/inward/record.url?eid=2-s2.0-0027531607&partnerID=MN8TOARSSchomburg, A. and Kirchner, H. and Fenner, M. and Menzel, T. and Poliwoda, H. and Atzpodien, J., (1993). "Lack of therapeutic efficacy of tamoxifen in advanced renal cell carcinoma", European Journal of Cancer Part A: General Topics, vol. 29, no. 5, pp. 737-740 -
Public
Ligands for PPARγ and RAR cause induction of growth inhibition and apoptosis in human glioblastomas: Journal of Neuro-Oncology 2003
DOI: 10.1023/B:NEON.0000003728.80052.a8www.scopus.com/inward/record.url?eid=2-s2.0-0348136061&partnerID=MN8TOARSZang, C. and Wächter, M. and Liu, H. and Posch, M.G. and Fenner, M.H. and Stadelmann, C. and Von Deimling, A. and Possinger, K. and Black, K.L. and Koeffler, H.P. and Elstner, E., (2003). "Ligands for PPARγ and RAR cause induction of growth inhibition and apoptosis in human glioblastomas", Journal of Neuro-Oncology, vol. 65, no. 2, pp. 107-118 -
Public
Limited efficacy of interferon-α and vinblastine as second line biochemotherapy regimen in patients with progressive metastatic renal cell carcinoma: Cancer Biotherapy 1993
www.scopus.com/inward/record.url?eid=2-s2.0-0027333291&partnerID=MN8TOARSHanninen, E.L. and Fenner, M. and Kirchner, H. and Deckert, M. and Duensing, S. and Menzel, T. and Poliwoda, H. and Atzpodien, J., (1993). "Limited efficacy of interferon-α and vinblastine as second line biochemotherapy regimen in patients with progressive metastatic renal cell carcinoma", Cancer Biotherapy, vol. 8, no. 4, pp. 301-306 -
Public
MSG1 (melanocyte-specific gene 1): Mapping to chromosome Xq13.1, genomic organization, and promoter analysis: Genomics 1998
DOI: 10.1006/geno.1998.5383www.scopus.com/inward/record.url?eid=2-s2.0-0032143051&partnerID=MN8TOARSFenner, M.H. and Parrish, J.E. and Boyd, Y. and Reed, V. and MacDonald, M. and Nelson, D.L. and Isselbacher, K.J. and Shioda, T., (1998). "MSG1 (melanocyte-specific gene 1): Mapping to chromosome Xq13.1, genomic organization, and promoter analysis", Genomics, vol. 51, no. 3, pp. 401-407 -
Public
MSG1 and its related protein MRG1 share a transcription activating domain Dec-1997
DOI: 10.1016/S0378-1119(97)00551-9Shioda, T, Fenner, M & Isselbacher, K, 1997, 'MSG1 and its related protein MRG1 share a transcription activating domain', Gene, vol. 93, no. 1-2, pp. 10321-241. -
Public
Neuropsychiatric symptoms during treatment with interleukin-2 and interferon-α [8]: Lancet 1993
www.scopus.com/inward/record.url?eid=2-s2.0-0027392704&partnerID=MN8TOARSFenner, M.H. and Hanninen, E.L. and Kirchner, H.H. and Poliwoda, H. and Atzpodien, J., (1993). "Neuropsychiatric symptoms during treatment with interleukin-2 and interferon-α [8]", Lancet, vol. 341, no. 8841 -
Public
Novel therapeutic approach: Ligands for PPARγ and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells: Breast Cancer Research and Treatment 2002
DOI: 10.1023/A:1016114026769www.scopus.com/inward/record.url?eid=2-s2.0-0035990751&partnerID=MN8TOARSElstner, E. and Williamson, E.A. and Zang, C. and Fritz, J. and Heber, D. and Fenner, M. and Possinger, K. and Koeffler, H.P., (2002). "Novel therapeutic approach: Ligands for PPARγ and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells", Breast Cancer Research and Treatment, vol. 74, no. 2, pp. 155-165 -
Public
ORCID: A system to uniquely identify researchers: Learned Publishing 2012
DOI: 10.1087/20120404www.scopus.com/inward/record.url?eid=2-s2.0-84867118127&partnerID=MN8TOARSHaak, L.L. and Fenner, M. and Paglione, L. and Pentz, E. and Ratner, H., (2012). "ORCID: A system to uniquely identify researchers", Learned Publishing, vol. 25, no. 4, pp. 259-264 -
Public
ORCID: Unique Identifiers for Authors and Contributors Jun-2011
DOI: 10.3789/isqv23n3.2011.3Fenner, M, 2011, 'ORCID: Unique Identifiers for Authors and Contributors', Information Standards Quarterly, vol. 23, no. 3, p. 10. -
Public
One-click science marketing Mar-2012
DOI: 10.1038/nmat3283Fenner, M, 2012, 'One-click science marketing', Nature Materials, vol. 5, no. 4, pp. e1000263-263. -
Public
PPARγ ligands and ATRA inhibit the invasion of human breast cancer cells in vitro: Breast Cancer Research and Treatment 2003
DOI: 10.1023/A:1023366117157www.scopus.com/inward/record.url?eid=2-s2.0-0038703477&partnerID=MN8TOARSLiu, H. and Zang, C. and Fenner, M.H. and Possinger, K. and Elstner, E., (2003). "PPARγ ligands and ATRA inhibit the invasion of human breast cancer cells in vitro", Breast Cancer Research and Treatment, vol. 79, no. 1, pp. 63-74 -
Public
Peroxisome proliferator-activated receptor γ ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia: Leukemia Research 2004
DOI: 10.1016/j.leukres.2003.07.005www.scopus.com/inward/record.url?eid=2-s2.0-10744219838&partnerID=MN8TOARSZang, C. and Liu, H. and Posch, M.G. and Waechter, M. and Facklam, M. and Fenner, M.H. and Ruthardt, M. and Possinger, K. and Koeffler, H.P. and Elstner, E., (2004). "Peroxisome proliferator-activated receptor γ ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia", Leukemia Research, vol. 28, no. 4, pp. 387-397 -
Public
Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer Jun-2005
DOI: 10.1517/13543784.14.6.557Fenner, M & Elstner, E, 2005, 'Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer', Expert Opinion on Investigational Drugs, vol. 8, no. 6, pp. 395-568.<">